SU1690701A1 - Method for peritonitis treatment - Google Patents
Method for peritonitis treatment Download PDFInfo
- Publication number
- SU1690701A1 SU1690701A1 SU894705361A SU4705361A SU1690701A1 SU 1690701 A1 SU1690701 A1 SU 1690701A1 SU 894705361 A SU894705361 A SU 894705361A SU 4705361 A SU4705361 A SU 4705361A SU 1690701 A1 SU1690701 A1 SU 1690701A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- liters
- abdominal cavity
- treatment
- oxygenated
- day
- Prior art date
Links
- 206010034674 peritonitis Diseases 0.000 title claims abstract description 5
- 238000000034 method Methods 0.000 title claims description 4
- 210000000683 abdominal cavity Anatomy 0.000 claims abstract description 7
- 229920000831 ionic polymer Polymers 0.000 claims abstract 5
- 239000003242 anti bacterial agent Substances 0.000 claims abstract 3
- 229940088710 antibiotic agent Drugs 0.000 claims abstract 3
- 238000000502 dialysis Methods 0.000 claims description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 238000012084 abdominal surgery Methods 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 238000005406 washing Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 5
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 229940021013 electrolyte solution Drugs 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 238000002692 epidural anesthesia Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 238000002682 general surgery Methods 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 description 1
- 229960005287 lincomycin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- RARSHUDCJQSEFJ-UHFFFAOYSA-N p-Hydroxypropiophenone Chemical compound CCC(=O)C1=CC=C(O)C=C1 RARSHUDCJQSEFJ-UHFFFAOYSA-N 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000005518 polymer electrolyte Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Изобретение относитс к медицине, в частности к абдоминальной хирургии, и может быть использовано дл лечени острого перитонита. Целью изобретени вл етс предупреждение осложнений и сокращение сроков лечени . Эта цель достигаетс тем, что производ т механическое промывание брюшной полости 1,5-2 л полиионных растворов в проточном режиме в течение 10-15 мин, а затем ввод т в брюшную полость оксигенерированные полиионные растворы с антибиотиками в дозе 2,5-3 л на 3-4 ч, 3-4 раза в сутки.The invention relates to medicine, in particular to abdominal surgery, and can be used for the treatment of acute peritonitis. The aim of the invention is to prevent complications and reduce the duration of treatment. This goal is achieved by producing a mechanical washing of the abdominal cavity with 1.5-2 liters of polyionic solutions in a flow-through mode for 10-15 minutes, and then oxygenated polyionic solutions with antibiotics in a dose of 2.5-3 liters are introduced into the abdominal cavity. 3-4 hours, 3-4 times a day.
Description
Изобретение относитс к медицине, в частности к абдоминазной хирургии и может быть использовано дл лечени острого перитонита.The invention relates to medicine, in particular to abdominal surgery and can be used to treat acute peritonitis.
Целью изобретени вл етс предупреждение осложнений и сокращение сроков лечени .The aim of the invention is to prevent complications and reduce the duration of treatment.
Способ по сн етс следующим примером .The method is illustrated by the following example.
Пример. Больной К. С., 24 лет, поступил в клинику с диагнозом острый разлитой перитонит.Example. Patient K.S., 24 years old, was admitted to the hospital with a diagnosis of acute diffuse peritonitis.
После операции сразу начата инфузион- на и антибактериальна терапи (тетролен, линкомицин в/в). Через 4 ч после операции начат оксигенированный перитонеальный диализ по предложенному способу. В качестве диализата использовалс р-р Рингера. В 1 сут дополнительно примен лс водный 0,05% р-р хлоргексидина биглюконата по 40 мл. Диализат оксигенировалс в оксигенаторе под давлением 750 мм рт. ст. в течение 45 мин. Перва порци оксигенированного раствора в объеме 1,5 л вводилось в брюшную полость через верхний дренаж струйноAfter the operation, infusion- and antibacterial therapy (tetrolen, lincomycin IV) was immediately started. Four hours after the operation, oxygenated peritoneal dialysis was started using the proposed method. Ringer was used as dialysate. In 1 day, an additional 0.05% solution of chlorhexidine digluconate in 40 ml was added. Dialysate was oxygenated in an oxygenator under a pressure of 750 mmHg. Art. within 45 min. The first portion of the oxygenated solution in a volume of 1.5 liters was introduced into the abdominal cavity through the upper drainage jet
на 10-15 мин, после чего сразу диализат удал лс . Втора порци оксигенированного раствора (1,5 л) с добавлением 80 мг ген- тамицина вводилась при пережатых нижних дренажах струйно в верхний дренаж, ко то- рый после этого перекрывалс . Парциальное давление кислорода в растворе 77 мм рт. ст. Экспозици 4 ч, во врем экспозиции производилось активное и пассивное перемещени внутренних органов, после чего диализат удал лс . В первые сутки больной находилс на ИВЛ, перитонеальный диализ проводилс 4 раза с экспозицией по 4 часа. Диализат темный мутный. Проводилась необходима интенсивна терапи , а также декомпресси кишечника с пассивно- активной аспирацией мономерными-электролитными растворами в объеме 3 л.for 10-15 minutes, after which the dialysate was immediately removed. A second portion of the oxygenated solution (1.5 liters) with the addition of 80 mg of gentamicin was injected when the lower drains were squeezed in a jet into the upper drainage, which then overlapped. The partial pressure of oxygen in the solution is 77 mm Hg. Art. Exposure was 4 hours. During the exposure, active and passive movement of the internal organs was performed, after which the dialysate was removed. On the first day, the patient was on artificial lung ventilation, peritoneal dialysis was performed 4 times with an exposure of 4 hours. Dialysate dark muddy. Intensive therapy was carried out, as well as intestinal decompression with passive-active aspiration with monomer-electrolyte solutions in a volume of 3 liters.
. На вторые сутки больной переведен на самосто тельное дыхание, начата фармакологическа стимул ци кишечника и длительна перидуральна анестези . Проводилось энтеральное зондовое питание полимерно-электролитными растворами в объеме 1 л и декомпресси кишечника.. On the second day, the patient was transferred to spontaneous breathing, pharmacological stimulation of the intestines was initiated, and long-term epidural anesthesia was started. Enteral feeding of polymer-electrolyte solutions was carried out in a volume of 1 l and intestinal decompression.
(Л(L
СWITH
о ю оoh oh
33
Перитонеальный диализ проводилс аналогично , диализат просветлел. К исходу 2-х суток по вилась слаба перистальтика и был самосто тельный жидкий стул в количестве 200 мл. В течение 3 и 4-х суток перито- неальный диализ, учитыва просветление диализата, и улучшение картины экспресс- бактериоскопии, проводилс 3 раза с экспозицией по 3 ч, парциальное давление кислорода в растворе 600 мм рт. ст. К концу 4-х суток диализат очистилс , светлый, про- зрачный, на экспресс-бактериоскопии отмечаютс единичные граммотрицательные палочки, бак. посев экссудата в аэробных и анаэробных услови х стерильный. В св зи с этим перитонеальный диализ прекращен и на 5-е сутки дренажи из брюшной полости удалены, больной переведен из реанимационного отделени в общехирургическое. Из анализов на 5-е сутки: гемоглобин 100 г/л; эритроциты 3,2х1012/л, лейкоцитыPeritoneal dialysis was carried out similarly, dialysate became clear. By the end of 2 days, peristalsis was weak and there was an independent liquid stool in the amount of 200 ml. For 3 and 4 days, peritoneal dialysis, taking into account the cleansing of dialysate, and the improvement of the express-bacterioscopy picture, was carried out 3 times with an exposure of 3 hours, the partial pressure of oxygen in the solution was 600 mm Hg. Art. By the end of 4 days, the dialysate was cleansed, light, transparent, on the express bacterioscopy, single gram-negative rods, tank were observed. Seeding exudates in aerobic and anaerobic conditions is sterile. In connection with this, peritoneal dialysis was discontinued and on the 5th day the drainage from the abdominal cavity was removed, the patient was transferred from the intensive care unit to the general surgery room. From tests on the 5th day: hemoglobin 100 g / l; erythrocytes 3,2х1012 / l, leukocytes
9,9x10 /л, мочевина 8,5 ммоль/л, креатинин 127,5 мк моль/л, общий белок 64,2 г/л, на 8-е сутки сн ты швы с раны, заживление первичное. Больной в удовлетворительном состо нии выписан домой.9.9x10 / l, urea 8.5 mmol / l, creatinine 127.5 μmol / l, total protein 64.2 g / l, on the 8th day, remove the stitches from the wound, healing is primary. The patient in a satisfactory condition was discharged home.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU894705361A SU1690701A1 (en) | 1989-06-29 | 1989-06-29 | Method for peritonitis treatment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU894705361A SU1690701A1 (en) | 1989-06-29 | 1989-06-29 | Method for peritonitis treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU1690701A1 true SU1690701A1 (en) | 1991-11-15 |
Family
ID=21454246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU894705361A SU1690701A1 (en) | 1989-06-29 | 1989-06-29 | Method for peritonitis treatment |
Country Status (1)
| Country | Link |
|---|---|
| SU (1) | SU1690701A1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2148954C1 (en) * | 1996-06-27 | 2000-05-20 | Кулиш Николай Иванович | Method for treating the cases of peritonitis |
| WO2002053110A3 (en) * | 2001-01-04 | 2002-12-05 | Beniamino Palmieri | Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| MD2664G2 (en) * | 2004-09-03 | 2005-09-30 | ЛЕПЭДАТУ Корнелиу | Method of treatment of the purulent generalized peritonitis |
-
1989
- 1989-06-29 SU SU894705361A patent/SU1690701A1/en active
Non-Patent Citations (1)
| Title |
|---|
| Шалимов А. А., Шамошников В. И., Пин- чукМ. П. Острый перитонит, 1981, с. 12,168. * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2148954C1 (en) * | 1996-06-27 | 2000-05-20 | Кулиш Николай Иванович | Method for treating the cases of peritonitis |
| WO2002053110A3 (en) * | 2001-01-04 | 2002-12-05 | Beniamino Palmieri | Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| MD2664G2 (en) * | 2004-09-03 | 2005-09-30 | ЛЕПЭДАТУ Корнелиу | Method of treatment of the purulent generalized peritonitis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Boen et al. | Periodic peritoneal dialysis using the repeated puncture technique and an automatic cycling machine | |
| US7053059B2 (en) | Dialysis solutions with reduced levels of glucose degradation products | |
| WO1984001904A1 (en) | A device for rinsing and treating wounds and infected skin portions | |
| Brewer et al. | Indwelling peritoneal (Tenckhoff) dialysis catheter: experience with 24 patients | |
| DE2809303A1 (en) | METHOD AND DEVICE FOR CONTINUOUS AMBULANCE PERITONEAL DIALYSIS (ABDOMINAL FLUSHING) | |
| SU1690701A1 (en) | Method for peritonitis treatment | |
| RU2140769C1 (en) | Method of treatment of odontogenous phlegmons of maxillofacial region | |
| RU2000788C1 (en) | Method for treatment of self-poisoning | |
| RU2154505C1 (en) | Method for treating abdominal cavity in acute peritonitis cases | |
| SU1409233A1 (en) | Method of treatment of acute destructive pancreatitis | |
| RU2122835C1 (en) | Method of ozonotherapy in peritonitis patients | |
| RU2154997C1 (en) | Method of treating generalized peritonitis | |
| RU2016553C1 (en) | Method of treating postpartum and postabortion endometrites | |
| RU2842825C1 (en) | Method of treating diffuse purulent peritonitis | |
| RU2388505C1 (en) | Method of abdominal cavity sanation by general peritonitis | |
| RU2249451C2 (en) | Method for treating acute purulent inflammation in serous cavity | |
| SU1581288A1 (en) | Method of preventing suppurations of operative wounds of children | |
| RU2029504C1 (en) | Method for preventing post-operative complications | |
| RU2631561C1 (en) | Method for treating acute widespread purulent peritonitis | |
| RU2071357C1 (en) | Method for ductory drainage of lymphatic system at peritonitis | |
| SU1699424A1 (en) | Method for prognoses of course of peritonitis | |
| SU1421317A1 (en) | Method of treatment of acute purulent peritonitis | |
| SU939011A1 (en) | Method of treating toxicosis | |
| RU2822409C1 (en) | Method for prevention of suture inconsistency during suturing of perforated gastroduodenal ulcer in conditions of peritonitis | |
| SU1657158A1 (en) | A method of treating acute epididymoorchitis |